Patents Assigned to Meridian Research and Development, Inc.
-
Patent number: 10653738Abstract: Topical medications to treat the physical effects of bruises and burns. For bruises, the topical medication preferably includes therapeutically effective amounts of vasoconstrictor, such as phenylephrine HCL USP, an anti-inflammatory, such as Arica, and compounding agents. In one embodiment, the compounding agents are a Versabase® gel which includes water, ammonium acryloyldimethyltaurate copolymer, aloe barbadensis leaf juice powder, allatoin, disodium EDTA, methylchloroisothiazolinone and methylisothiazolinone. For burns, the topical medication preferably combines therapeutically effective amounts of an active anti-bacterial compound, such as silver sulfadiazine, an anesthetic, such as lidocaine, and a histamine blocker, such as diphenhydramine, with suitable compounding agents, such as Versabase® gel. Both the anti-bruise and anti-burn medications of the present invention can advantageously be formulated in solutions, lotions, creams, ointments, gels, foams or transdermal patches.Type: GrantFiled: July 22, 2014Date of Patent: May 19, 2020Assignee: Meridian Research and Development Inc.Inventor: Ronald F. DeMeo
-
Patent number: 10052356Abstract: Topical medications to treat the physical effects of bruises and burns. For bruises, the topical medication preferably includes therapeutically effective amounts of vasoconstrictor, such as phenylephrine HCL USP, an anti-inflammatory, such as Arica, and compounding agents. In one embodiment, the compounding agents are a Versabase® gel which includes water, ammonium acryloyldimethyltaurate copolymer, aloe barbadensis leaf juice powder, allatoin, disodium EDTA, methylchloroisothiazolinone and methylisothiazolinone. For burns, the topical medication preferably combines therapeutically effective amounts of an active anti-bacterial compound, such as silver sulfadiazine, an anesthetic, such as lidocaine, and a histamine blocker, such as diphenhydramine, with suitable compounding agents, such as Versabase® gel. Both the anti-bruise and anti-burn medications of the present invention can advantageously be formulated in solutions, lotions, creams, ointments, gels, foams or transdermal patches.Type: GrantFiled: June 22, 2016Date of Patent: August 21, 2018Assignee: Meridian Research and Development, Inc.Inventor: Ronald F. DeMeo
-
Publication number: 20160296576Abstract: Topical medications to treat the physical effects of bruises and burns. For bruises, the topical medication preferably includes therapeutically effective amounts of vasoconstrictor, such as phenylephrine HCL USP, an anti-inflammatory, such as Arica, and compounding agents. In one embodiment, the compounding agents are a Versabase® gel which includes water, ammonium acryloyldimethyltaurate copolymer, aloe barbadensis leaf juice powder, allatoin, disodium EDTA, methylchloroisothiazolinone and rnethylisothiazolinone. For burns, the topical medication preferably combines therapeutically effective amounts of an active anti-bacterial compound, such as silver sulfadiazine, an anesthetic, such as lidocaine, and a histamine blocker, such as diphenhydramine, with suitable compounding agents, such as Versabase® gel. Both the anti-bruise and anti-burn medications of the present invention can advantageously be formulated in solutions, lotions, creams, ointments, gels, foams or transdermal patches.Type: ApplicationFiled: June 22, 2016Publication date: October 13, 2016Applicant: Meridian Research and Development, Inc.Inventor: Ronald F. DeMeo
-
Publication number: 20140374628Abstract: A method of making metal nanoparticles comprising contacting metal with a diazonium compound substituted with an organic substituent and allowing said metal to react with the diazonium compound thereby forming metal nanoparticles wherein each of said metal nanoparticles comprises a metal core bonded to an outer layer of said organic substituent as well as nanoparticles made by that method.Type: ApplicationFiled: August 25, 2014Publication date: December 25, 2014Applicant: Meridian Research and Development, Inc.Inventors: Ronald F. DeMeo, James Bradshaw, Frederico Polo
-
Patent number: 8858408Abstract: A double loop exercise strap that includes both an outer strap anchored to a fixed object (e.g., a wall, rail or other fixed platform) and an inner strap that wraps firmly around a limb, extremity (e.g., hand or foot) or torso of the human body. The inner strap has two ends, a fixed end that may advantageously be sewn or attached to the outer strap and a free end that wraps around the human limb, extremity or torso and is threaded through an outer strap slot before being attached to the outside of the outer strap using VELCRO™, buckles or other types of fasteners to thereby create a closed double loop system.Type: GrantFiled: December 6, 2011Date of Patent: October 14, 2014Assignee: Meridian Research and Development, Inc.Inventor: Ronald F. DeMeo
-
Publication number: 20130143724Abstract: An double loop exercise strap that includes both an outer strap anchored to a fixed object (e.g., a wall, rail or other fixed platform) and an inner strap that wraps firmly around a limb, extremity (e.g., hand or foot) or torso of the human body.Type: ApplicationFiled: December 6, 2011Publication date: June 6, 2013Applicant: Meridian Research and Development, Inc.Inventor: Ronald F. DeMeo
-
Publication number: 20120223258Abstract: Provided herein are metal nanoparticles, metal nanopowders, methods of synthesizing the same, and radiation shields using the same.Type: ApplicationFiled: April 2, 2010Publication date: September 6, 2012Applicant: Meridian Research and Development, IncInventors: Ronald F. DeMeo, James Adam Bradshaw, Federico Polo
-
Publication number: 20120108400Abstract: High Intensity Repetitious Training (HIRT) is an exercise regimen consisting of approximately three minutes of intense exercise that puts an exerciser at the end of the anaerobic energy transfer system and prevents the exerciser from entering the aerobic energy transfer system. The HIRT Program exercise regimen subjects the muscles to high frequency intense muscle contractions for approximately three minutes to the point that the lactic system reaches a maximum followed by a period of rest for at least one to two minutes to restore creatinine and remove some of the lactate acid out of the blood stream. The HIRT exercise regimen enhances the benefits of lactate accumulation, post-exercise insulin and growth hormone release with lipolysis or fat reduction.Type: ApplicationFiled: October 27, 2010Publication date: May 3, 2012Applicant: Meridian Research and Development, Inc.Inventor: Ronald F. DeMeo
-
Publication number: 20090000007Abstract: The present invention provides a breathable, lightweight material which has radiopaque qualities and is easy to produce. In the preferred embodiment, a lightweight fabric, such as a surgical mask liner or an entire surgical gown, is formed by mixing a lightweight radiopaque compound, such as barium sulfate, with a polymer filler, preferably polyethylene, to impart radiopaque qualities to the mixture, then extruding the mixture into a plurality of filaments to form a porous, nonwoven fabric mass, and forming the filament mass into a web suitable to be used as a garment liner or ply in a multi-ply fabric.Type: ApplicationFiled: May 22, 2008Publication date: January 1, 2009Applicant: Meridian Research and Development, Inc.Inventor: Ronald F. DeMeo